Resources from the same session
Welcome and introduction
Presenter: Pilar Garrido Lopez
Session: ESMO Colloquium supported by Eli Lilly and Company - Optimising diagnosis and management of patients with oncogene-addicted localised non-small cell lung cancer
Resources:
Webcast
How to optimise the science and workflows for biomarker testing in localised NSCLC: Tissue and plasma
Presenter: Frederique Penault-Llorca
Session: ESMO Colloquium supported by Eli Lilly and Company - Optimising diagnosis and management of patients with oncogene-addicted localised non-small cell lung cancer
Resources:
Slides
Webcast
State-of-the-art biomarker-driven management of patients with oncogene-addicted localised NSCLC
Presenter: Pilar Garrido Lopez
Session: ESMO Colloquium supported by Eli Lilly and Company - Optimising diagnosis and management of patients with oncogene-addicted localised non-small cell lung cancer
Resources:
Slides
Webcast
Ongoing clinical research activity for patients with localised oncogene-addicted NSCLC
Presenter: Fabrice Barlesi
Session: ESMO Colloquium supported by Eli Lilly and Company - Optimising diagnosis and management of patients with oncogene-addicted localised non-small cell lung cancer
Resources:
Slides
Webcast
Q&A
Session: ESMO Colloquium supported by Eli Lilly and Company - Optimising diagnosis and management of patients with oncogene-addicted localised non-small cell lung cancer
Resources:
Webcast
Concluding remarks
Presenter: Mariana Brandao
Session: ESMO Colloquium supported by Eli Lilly and Company - Optimising diagnosis and management of patients with oncogene-addicted localised non-small cell lung cancer
Resources:
Webcast